Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-25T19:18:08.009Z Has data issue: false hasContentIssue false
  • English
  • Français

Twisting the night away: a review of the neurobiology, genetics, diagnosis, and treatment of shift work disorder

Published online by Cambridge University Press:  18 December 2013

Debbi Ann Morrissette
Debbi Ann Morrissette*
Affiliation:
Department of Biological Sciences, California State University, San Marcos, California, USA; Department of Biological Sciences, Palomar Community College, San Marcos, California, USA; Neuroscience Education Institute, Carlsbad, California, USA
*
*Address for correspondence: Debbi Ann Morrissette, PhD, Neuroscience Education Institute, 1930 Palomar Point Way, Suite 101, Carlsbad, CA 92008, USA. (Email: dmorrissette@neiglobal.com)
Get access Rights & Permissions [Opens in a new window]

Abstract

Although not all individuals who work outside of standard daytime hours develop physical and psychiatric issues, there is a substantial portion of shift workers who develop shift work disorder. Shift work disorder is due to a misalignment between an individual's endogenous circadian rhythms and environmental stimuli, and can have potentially serious consequences to an individual's health and quality of life. This article reviews the neurobiological and genetic underpinnings of shift work disorder, and describes how desynchronization of the molecular clock may lead to both physical and psychiatric illnesses. Diagnostic tools and treatment guidelines to address the circadian misalignment, excessive sleepiness, and insomnia experienced by patients with shift work disorder are also discussed.

Keywords

Armodafinilcircadian rhythm disordermelatoninmolecular clockmodafinil
Type
CME Review Article
Information
CNS Spectrums , Volume 18 , Issue s1: CME SUPPLEMENT , December 2013 , pp. 42 - 54
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

This CME article is supported by an educational grant from Teva Pharmaceutical Industries Ltd.

References

1.Wright, KP Jr, Bogan, RK, Wyatt, JK. Shift work and the assessment and management of shift work disorder (SWD). Sleep Med Rev. 2013; 17(1): 41–54.Google Scholar
2.Barger, LK, Ogeil, RP, Drake, CL, etal. Validation of a questionnaire to screen for shift work disorder. Sleep. 2012; 35(12): 1693–1703.Google Scholar
3.Di Milia, L, Waage, S, Pallesen, S, Bjorvatn, B. Shift work disorder in a random population sample—prevalence and comorbidities. PLoS One. 2013; 8(1): e55306.Google Scholar
4.Saksvik, IB, Bjorvatn, B, Hetland, H, Sandal, GM, Pallesen, S. Individual differences in tolerance to shift work—a systematic review. Sleep Med Rev. 2011; 15(4): 221–235.CrossRefGoogle ScholarPubMed
5.Culpepper, L. The social and economic burden of shift-work disorder. J Fam Pract. 2010; 59(1 Suppl): S3–S11.Google Scholar
6.Schwartz, JR. Recognition of shift-work disorder in primary care. J Fam Pract. 2010; 59(1 Suppl): S18–S23.Google Scholar
7. Recognition and assessment of shift work disorder. J Clin Psychiatry. 2011;72(2):248–257.CrossRefGoogle Scholar
8.Buhr, ED, Takahashi, JS. Molecular components of the mammalian circadian clock. Handb Exp Pharmacol. 2013;(217): 3–27.CrossRefGoogle Scholar
9.Shigeyoshi, Y, Taguchi, K, Yamamoto, S, etal. Light-induced resetting of a mammalian circadian clock is associated with rapid induction of the mPer1 transcript. Cell. 1997; 91(7): 1043–1053.Google Scholar
10.Stahl, SM. Stahl's Essential Psychopharmacology, 4th ed. New York: Cambridge University Press; 2013.Google Scholar
11.Vogel, M, Braungardt, T, Meyer, W, Schneider, W. The effects of shift work on physical and mental health. J Neural Transm. 2012; 119(10): 1121–1132.Google Scholar
12.Lamont, EW, James, FO, Boivin, DB, Cermakian, N. From circadian clock gene expression to pathologies. Sleep Med. 2007; 8(6): 547–556.CrossRefGoogle ScholarPubMed
13.Leloup, JC, Goldbeter, A. Modelling the dual role of Per phosphorylation and its effect on the period and phase of the mammalian circadian clock. IET Syst Biol. 2011; 5(1): 44.Google Scholar
14.Rouch, I, Wild, P, Ansiau, D, Marquie, JC. Shiftwork experience, age and cognitive performance. Ergonomics. 2005; 48(10): 1282–1293.Google Scholar
15.Wagstaff, AS, Sigstad Lie, JA. Shift and night work and long working hours—a systematic review of safety implications. Scand J Work Environ Health. 2011; 37(3): 173–185.Google Scholar
16.Froy, O. Metabolism and circadian rhythms—implications for obesity. Endocr Rev. 2010; 31(1): 1–24.CrossRefGoogle ScholarPubMed
17.Boggild, H, Knutsson, A. Shift work, risk factors and cardiovascular disease. Scand J Work Environ Health. 1999; 25(2): 85–99.Google Scholar
18.Green, CB, Takahashi, JS, Bass, J. The meter of metabolism. Cell. 2008; 134(5): 728–742.Google Scholar
19.Wang, XS, Armstrong, ME, Cairns, BJ, Key, TJ, Travis, RC. Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond). 2011; 61(2): 78–89.Google Scholar
20.Straif, K, Baan, R, Grosse, Y, etal. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007; 8(12): 1065–1066.Google Scholar
21.Ravindra, T, Lakshmi, NK, Ahuja, YR. Melatonin in pathogenesis and therapy of cancer. Indian J Med Sci. 2006; 60(12): 523–535.Google Scholar
22.Rodriguez, C, Martin, V, Herrera, F, etal. Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells. Int J Mol Sci. 2013; 14(4): 6597–6613.Google Scholar
23.Takahashi, JS, Hong, HK, Ko, CH, McDearmon, EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet. 2008; 9(10): 764–775.Google Scholar
24.Nojkov, B, Rubenstein, JH, Chey, WD, Hoogerwerf, WA. The impact of rotating shift work on the prevalence of irritable bowel syndrome in nurses. Am J Gastroenterol. 2010; 105(4): 842–847.Google Scholar
25.Konturek, PC, Brzozowski, T, Konturek, SJ. Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol. 2011; 62(2): 139–150.Google Scholar
26.Knutsson, A, Boggild, H. Gastrointestinal disorders among shift workers. Scand J Work Environ Health. 2010; 36(2): 85–95.Google Scholar
27.Hoogerwerf, WA. Role of clock genes in gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol. 2010; 299(3): G549–G555.CrossRefGoogle ScholarPubMed
28.Lu, WZ, Gwee, KA, Moochhalla, S, Ho, KY. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2005; 22(10): 927–934.CrossRefGoogle ScholarPubMed
29.Meyer, JH, Ginovart, N, Boovariwala, A, etal. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry. 2006; 63(11): 1209–1216.Google Scholar
30.Drake, CL, Roehrs, T, Richardson, G, Walsh, JK, Roth, T. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep. 2004; 27(8): 1453–1462.Google Scholar
31.Boivin, DB, Boudreau, P, James, FO, Kin, NM. Photic resetting in night-shift work: impact on nurses’ sleep. Chronobiol Int. 2012; 29(5): 619–628.Google Scholar
32.Boivin, DB, Boudreau, P, Tremblay, GM. Phototherapy and orange-tinted goggles for night-shift adaptation of police officers on patrol. Chronobiol Int. 2012; 29(5): 629–640.Google Scholar
33.Dallaspezia, S, Benedetti, F. Chronobiological therapy for mood disorders. Expert Rev Neurother. 2011; 11(7): 961–970.Google Scholar
34.Terman, M, Terman, JS. Circadian rhythm phase advance with dawn simulation treatment for winter depression. J Biol Rhythms. 2010; 25(4): 297–301.Google Scholar
35.Roth, T. Appropriate therapeutic selection for patients with shift work disorder. Sleep Med. 2012; 13(4): 335–341.Google Scholar
36.Folkard, S, Arendt, J, Clark, M. Can melatonin improve shift workers’ tolerance of the night shift? Some preliminary findings. Chronobiol Int. 1993; 10(5): 315–320.Google Scholar
37.Yoon, IY, Song, BG. Role of morning melatonin administration and attenuation of sunlight exposure in improving adaptation of night-shift workers. Chronobiol Int. 2002; 19(5): 903–913.Google Scholar
38.Srinivasan, V, Spence, DW, Pandi-Perumal, SR, Trakht, I, Cardinali, DP. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs. Travel Med Infect Dis. 2008; 6(1–2): 17–28.Google Scholar
39.Markwald, RR, Lee-Chiong, TL, Burke, TM, Snider, JA, Wright, KP Jr. Effects of the melatonin MT-1/MT-2 agonist ramelteon on daytime body temperature and sleep. Sleep. 2010; 33(6): 825–831.Google Scholar
40.Wisor, JP, Eriksson, KS. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience. 2005; 132(4): 1027–1034.Google Scholar
41.Ishizuka, T, Murotani, T, Yamatodani, A. Action of modafinil through histaminergic and orexinergic neurons. Vitam Horm. 2012; 89: 259–278.Google Scholar
42.Gallopin, T, Luppi, PH, Rambert, FA, Frydman, A, Fort, P. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep. 2004; 27(1): 19–25.Google Scholar
43.Madras, BK, Xie, Z, Lin, Z, etal. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther. 2006; 319(2): 561–569.Google Scholar
44.Gerrard, P, Malcolm, R. Mechanisms of modafinil: a review of current research. Neuropsychiatr Dis Treat. 2007; 3(3): 349–364.Google Scholar
45.Bogan, RK. Armodafinil in the treatment of excessive sleepiness. Expert Opin Pharmacother. 2010; 11(6): 993–1002.Google Scholar
46.Darwish, M, Bond, M, Ezzet, F. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships. J Clin Pharmacol. 2012; 52(9): 1328–1342.Google Scholar
47.Darwish, M, Kirby, M, D'Andrea, DM, etal. Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study. Clin Ther. 2010; 32(12): 2074–2087.Google Scholar
48.Erman, MK, Seiden, DJ, Yang, R, Dammerman, R. Efficacy and tolerability of armodafinil: effect on clinical condition late in the shift and overall functioning of patients with excessive sleepiness associated with shift work disorder. J Occup Environ Med. 2011; 53(12): 1460–1465.Google Scholar
49.Jasinski, DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol. 2000; 14(1): 53–60.Google Scholar
50.Stahl, SM. ed. Stahl's Essential Psychopharmacology: The Prescriber's Guide, 4th ed. New York: Cambridge University Press; 2011.Google Scholar
51.Davies, M, Wilton, L, Shakir, S. Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescription-event monitoring study. Drug Saf. 2013; 36(4): 237–246.Google Scholar
52.Hart, CL, Ward, AS, Haney, M, Nasser, J, Foltin, RW. Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work. Psychopharmacology (Berl). 2003; 169(1): 42–51.CrossRefGoogle ScholarPubMed
53.Schweitzer, PK, Randazzo, AC, Stone, K, Erman, M, Walsh, JK. Laboratory and field studies of naps and caffeine as practical countermeasures for sleep-wake problems associated with night work. Sleep. 2006; 29(1): 39–50.Google Scholar
54.Ker, K, Edwards, PJ, Felix, LM, Blackhall, K, Roberts, I. Caffeine for the prevention of injuries and errors in shift workers. Cochrane Database Syst Rev. 2010;(5): CD008508.Google Scholar
55.Cauli, O, Morelli, M. Caffeine and the dopaminergic system. Behav Pharmacol. 2005; 16(2): 63–77.Google Scholar
56.Einother, SJ, Giesbrecht, T. Caffeine as an attention enhancer: reviewing existing assumptions. Psychopharmacology (Berl). 2013; 225(2): 251–274.Google Scholar